GENEVA, April 29 -- AVALO THERAPEUTICS, INC. (540 Gaither RoadSuite 400ROCKVILLE, Maryland 20850) filed a patent application (PCT/US2025/051139) for "LIQUID PHARMACEUTICAL FORMULATIONS FOR AN ANTI-IL-1BETA ANTIBODY" on Oct 15, 2025. With publication no. WO/2026/085262, the details related to the patent application was published on Apr 23, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): LE BRUN, Virginie (c/o Lonza AGMuenchensteinerstrasse 38CH-4002 Basel), MIANO, Dino C. (c/o Avalo Therapeutics, Inc.540 Gaither RoadSuite 400ROCKVILLE, Maryland 20850)
Abstract: The present disclosure relates...